New Drug Marketing Application_Providing professional financial news and data related to New Drug Marketing Application, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

HENGRUI PHARMA (01276.HK): NMPA accepts marketing application for atopic dermatitis antibody Zhuotuoqibai injection

Tags：

HENGRUI PHARMA 01276.HK New Drug Marketing Application

2026-09-04

CUTIA-B (02487.HK): BLA for CU-20101 botulinum toxin type A for injection accepted by NMPA

Tags：

CUTIA-B 02487.HK R&D Progress New Drug Marketing Application

2026-09-03

BOAN BIOTECH(06955.HK): Aflibercept Intravitreal Injection Submitted for Marketing Approval in Brazil for Wet AMD and Diabetic Macular Edema

Tags：

BOAN BIOTECH 06955.HK New Drug Marketing Application

2026-08-05

HENLIUS(02696.HK): Hanbeiyou (Pertuzumab Injection) Approved by NMPA for HER2-positive Breast Cancer Treatment

Tags：

HENLIUS 02696.HK New Drug Marketing Application

2026-05-29

INNOCARE(09969.HK): NDA of Orelabrutinib for ITP Accepted by NMPA

Tags：

INNOCARE 09969.HK New Drug Marketing Application

2026-05-28

INNOVENT BIO(01801.HK): Tyvyt® Plus Elunate® Approved for Advanced Renal Cell Carcinoma

Tags：

INNOVENT BIO 01801.HK New Drug Marketing Application

2026-05-21

Scan QR Code

Download App